Literature DB >> 10512748

Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.

S C Crawley1, J R Gum, J W Hicks, W S Pratt, J P Aubert, D M Swallow, Y S Kim.   

Abstract

The MUC3 gene encodes a large, glycosylated mucin produced by intestinal epithelial cells to form a protective barrier against the external environment. Recently published cDNA sequences for the carboxyl-terminal region of MUC3 polypeptide indicated that rodent Muc3 possesses two epidermal growth factor (EGF)-like domains, and putative transmembrane and cytoplasmic domains, whereas the sequence of human MUC3 predicted termination after the first EGF-like domain. Here we describe the complete genomic sequence encompassing the carboxyl terminal region of human MUC3, revealing the boundaries of 11 exons. RT-PCR and cDNA library cloning experiments indicate that the gene is alternatively spliced, yielding a major membrane-bound form as well as multiple soluble forms. Thus, this work indicates that both membrane-bound and soluble MUC3 mucin proteins are produced by alternative splicing of a single gene. A potentially important polymorphism involving a Tyr residue with a proposed role in signalling is described as well. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512748     DOI: 10.1006/bbrc.1999.1466

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucins.

Authors:  Samuel B Ho; Ying Luu; Laurie L Shekels; Surinder K Batra; Brandon Kandarian; David B Evans; Phillip G Zaworski; Cindy L Wolfe; Robert L Heinrikson
Journal:  Biochim Biophys Acta       Date:  2010-03-20

Review 2.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis.

Authors:  Ying Luu; Wade Junker; Satyanarayana Rachagani; Srustidhar Das; Surinder K Batra; Robert L Heinrikson; Laurie L Shekels; Samuel B Ho
Journal:  Int J Biochem Cell Biol       Date:  2010-03-06       Impact factor: 5.085

Review 4.  Genetic variants of mucins: unexplored conundrum.

Authors:  Sushil Kumar; Eric Cruz; Suhasini Joshi; Asish Patel; Rahat Jahan; Surinder K Batra; Maneesh Jain
Journal:  Carcinogenesis       Date:  2017-07-01       Impact factor: 4.944

5.  Coordinated Muc2 and Muc3 mucin gene expression in Trichinella spiralis infection in wild-type and cytokine-deficient mice.

Authors:  L L Shekels; R E Anway; J Lin; M W Kennedy; P Garside; C E Lawrence; S B Ho
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

6.  Mucin biosynthesis and secretion in tracheal epithelial cells in primary culture.

Authors:  N Svitacheva; J R Davies
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

Review 7.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

Review 8.  The gastrointestinal mucus system in health and disease.

Authors:  Malin E V Johansson; Henrik Sjövall; Gunnar C Hansson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-12       Impact factor: 46.802

9.  Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro.

Authors:  D R Mack; S Ahrne; L Hyde; S Wei; M A Hollingsworth
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

10.  Synthesis and secretion of Muc4/sialomucin complex: implication of intracellular proteolysis.

Authors:  Masanobu Komatsu; Maria E Arango; Kermit L Carraway
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.